Author

M. Dragoj

Listed by name: these papers carry no ORCID for this author, so different people with the same name may be mixed together.

Biology Disciplines

Click to filter author papers

Cancer Biology· 1

Signature Assays, Organisms & Methods

Click to filter · or open tag

Assay:bulk RNA-seq· 1 Research Focus:drug response / drug discovery· 1 Organism:human· 1 Organism:mouse· 1 Approach:statistical model· 1

Frequent Co-Authors

B. Segura-Collar· 1 shared J. Jimenez-Sanchez· 1 shared J. M. Sepulveda· 1 shared M. Pesic· 1 shared P. Sanchez-Gomez· 1 shared R. Gargini· 1 shared V. M. Perez-Garcia· 1 shared

Activity by Year

2022-2022 · peak 1/yr

Co-Author Collaboration Network

7 top collaborators · 21 mutual co-author links

Click any collaborator node to inspect or filter shared papers

Focal author (center)Selected co-authorORCID co-authorUnlinked name

Curved chords = mutual co-authorship

1 shared paperCancer Biology

B. Segura-Collar

Mutual co-authors in cluster

Author profile →

1 paper

Recent·Most cited

On optimal temozolomide scheduling for slowly growing gliomas

B. Segura-Collar, J. Jimenez-Sanchez, R. Gargini, M. Dragoj, J. M. Sepulveda, M. Pesic, P. Sanchez-Gomez, V. M. Perez-Garcia

This study uses in-silico models and experimental data to show that longer TMZ dose intervals improve survival and reduce toxicity in slowly growing gliomas by altering tumor phenotype.

bioRxiv · Mar 10, 2022 · PreprintCancer Biology